Sanofi And Regeneron Cut List Price Of Cholesterol Drug By 60 Percent

Sanofi and Regeneron Pharmaceuticals said they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Reuters ...